ne
Iraq – Federal (Baghdad) Opposition closed
Some details of this record were read from an image by OCR. Check them against the official bulletin.
| Notice | Application |
|---|---|
| Application no. | 99279 |
| Filing date | 2 May 2024 |
| Nice classes | 5 |
| Goods / services (English) | Class 5 (Pharmaceuticals), Iraqi sub-class a |
| Owner | GlaxoSmithKline Intellectual Property Limited |
| Address | GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom |
| Country | United Kingdom |
| Bulletin | No. 1441, first announced 13 Oct 2024, last announced 27 Oct 2024, page 160 |
| Opposition deadline | 25 Jan 2025 (90 days from the last announcement; confirm with the office) |
| Official source | Open the official bulletin (PDF) |